img

Global Vector-Based RNAi Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Vector-Based RNAi Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vector-based RNAi (RNA interference) offers a system of treatment and disease management to decrease the inhibition of gene translation or expression, as well as it neutralizes the targeted mRNA molecules. Vector-based RNAi plays very important in cancer treatment,cancer is the top second cause of death across the globe. As well as a new development in vector-based RNAi such as small interfering RNAs (siRNA) and microRNAs (miRNA) can escalate the vector-based RNAi market growth. The challenging situation of FDA approval affecting on a number of new drugs launch, for instance, 2015 (41 drugs), while in 2016 (19 drugs) which are very less as compared with the previous year.
Vector-Based RNAi report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Vector-Based RNAi market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Speciality Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Vector-Based RNAi industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Vector-Based RNAi key manufacturers include Merck & Co., Phio Pharmaceutical, Quark Pharmaceuticals, Thermo Fisher Scientific, Silence Therapeutics, Qiagen NV, Ionis Pharmaceutical, Dicerna Pharmaceuticals and Arrowhead Pharmaceuticals, etc. Merck & Co., Phio Pharmaceutical, Quark Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Vector-Based RNAi can be divided into siRNA Design, siRNA Vectors and Custom siRNA Construction,, etc. siRNA Design is the mainstream product in the market, accounting for % sales share globally in 2022.
Vector-Based RNAi is widely used in various fields, such as Hospitals and Speciality Clinics, etc. Hospitals provides greatest supports to the Vector-Based RNAi industry development. In 2022, global % sales of Vector-Based RNAi went into Hospitals filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Vector-Based RNAi market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck & Co.
Phio Pharmaceutical
Quark Pharmaceuticals
Thermo Fisher Scientific
Silence Therapeutics
Qiagen NV
Ionis Pharmaceutical
Dicerna Pharmaceuticals
Arrowhead Pharmaceuticals
Arcturus Therapeutics
Alnylam Pharmaceuticals
Segment by Type
siRNA Design
siRNA Vectors
Custom siRNA Construction

Segment by Application


Hospitals
Speciality Clinics

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Vector-Based RNAi market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Vector-Based RNAi, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Vector-Based RNAi industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Vector-Based RNAi in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Vector-Based RNAi introduction, etc. Vector-Based RNAi Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Vector-Based RNAi market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Vector-Based RNAi Market Overview
1.1 Vector-Based RNAi Product Overview
1.2 Vector-Based RNAi Market Segment by Type
1.2.1 siRNA Design
1.2.2 siRNA Vectors
1.2.3 Custom siRNA Construction
1.3 Global Vector-Based RNAi Market Size by Type
1.3.1 Global Vector-Based RNAi Market Size Overview by Type (2024-2034)
1.3.2 Global Vector-Based RNAi Historic Market Size Review by Type (2024-2024)
1.3.3 Global Vector-Based RNAi Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vector-Based RNAi Sales Breakdown by Type (2024-2024)
1.4.2 Europe Vector-Based RNAi Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Vector-Based RNAi Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Vector-Based RNAi Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Vector-Based RNAi Sales Breakdown by Type (2024-2024)
2 Global Vector-Based RNAi Market Competition by Company
2.1 Global Top Players by Vector-Based RNAi Sales (2024-2024)
2.2 Global Top Players by Vector-Based RNAi Revenue (2024-2024)
2.3 Global Top Players by Vector-Based RNAi Price (2024-2024)
2.4 Global Top Manufacturers Vector-Based RNAi Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vector-Based RNAi Market Competitive Situation and Trends
2.5.1 Vector-Based RNAi Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Vector-Based RNAi Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vector-Based RNAi as of 2022)
2.7 Date of Key Manufacturers Enter into Vector-Based RNAi Market
2.8 Key Manufacturers Vector-Based RNAi Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vector-Based RNAi Status and Outlook by Region
3.1 Global Vector-Based RNAi Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Vector-Based RNAi Historic Market Size by Region
3.2.1 Global Vector-Based RNAi Sales in Volume by Region (2024-2024)
3.2.2 Global Vector-Based RNAi Sales in Value by Region (2024-2024)
3.2.3 Global Vector-Based RNAi Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Vector-Based RNAi Forecasted Market Size by Region
3.3.1 Global Vector-Based RNAi Sales in Volume by Region (2024-2034)
3.3.2 Global Vector-Based RNAi Sales in Value by Region (2024-2034)
3.3.3 Global Vector-Based RNAi Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Vector-Based RNAi by Application
4.1 Vector-Based RNAi Market Segment by Application
4.1.1 Hospitals
4.1.2 Speciality Clinics
4.2 Global Vector-Based RNAi Market Size by Application
4.2.1 Global Vector-Based RNAi Market Size Overview by Application (2024-2034)
4.2.2 Global Vector-Based RNAi Historic Market Size Review by Application (2024-2024)
4.2.3 Global Vector-Based RNAi Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vector-Based RNAi Sales Breakdown by Application (2024-2024)
4.3.2 Europe Vector-Based RNAi Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Vector-Based RNAi Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Vector-Based RNAi Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Vector-Based RNAi Sales Breakdown by Application (2024-2024)
5 North America Vector-Based RNAi by Country
5.1 North America Vector-Based RNAi Historic Market Size by Country
5.1.1 North America Vector-Based RNAi Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Vector-Based RNAi Sales in Volume by Country (2024-2024)
5.1.3 North America Vector-Based RNAi Sales in Value by Country (2024-2024)
5.2 North America Vector-Based RNAi Forecasted Market Size by Country
5.2.1 North America Vector-Based RNAi Sales in Volume by Country (2024-2034)
5.2.2 North America Vector-Based RNAi Sales in Value by Country (2024-2034)
6 Europe Vector-Based RNAi by Country
6.1 Europe Vector-Based RNAi Historic Market Size by Country
6.1.1 Europe Vector-Based RNAi Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Vector-Based RNAi Sales in Volume by Country (2024-2024)
6.1.3 Europe Vector-Based RNAi Sales in Value by Country (2024-2024)
6.2 Europe Vector-Based RNAi Forecasted Market Size by Country
6.2.1 Europe Vector-Based RNAi Sales in Volume by Country (2024-2034)
6.2.2 Europe Vector-Based RNAi Sales in Value by Country (2024-2034)
7 Asia-Pacific Vector-Based RNAi by Region
7.1 Asia-Pacific Vector-Based RNAi Historic Market Size by Region
7.1.1 Asia-Pacific Vector-Based RNAi Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Vector-Based RNAi Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Vector-Based RNAi Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Vector-Based RNAi Forecasted Market Size by Region
7.2.1 Asia-Pacific Vector-Based RNAi Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Vector-Based RNAi Sales in Value by Region (2024-2034)
8 Latin America Vector-Based RNAi by Country
8.1 Latin America Vector-Based RNAi Historic Market Size by Country
8.1.1 Latin America Vector-Based RNAi Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Vector-Based RNAi Sales in Volume by Country (2024-2024)
8.1.3 Latin America Vector-Based RNAi Sales in Value by Country (2024-2024)
8.2 Latin America Vector-Based RNAi Forecasted Market Size by Country
8.2.1 Latin America Vector-Based RNAi Sales in Volume by Country (2024-2034)
8.2.2 Latin America Vector-Based RNAi Sales in Value by Country (2024-2034)
9 Middle East and Africa Vector-Based RNAi by Country
9.1 Middle East and Africa Vector-Based RNAi Historic Market Size by Country
9.1.1 Middle East and Africa Vector-Based RNAi Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Vector-Based RNAi Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Vector-Based RNAi Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Vector-Based RNAi Forecasted Market Size by Country
9.2.1 Middle East and Africa Vector-Based RNAi Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Vector-Based RNAi Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck & Co.
10.1.1 Merck & Co. Company Information
10.1.2 Merck & Co. Introduction and Business Overview
10.1.3 Merck & Co. Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck & Co. Vector-Based RNAi Products Offered
10.1.5 Merck & Co. Recent Development
10.2 Phio Pharmaceutical
10.2.1 Phio Pharmaceutical Company Information
10.2.2 Phio Pharmaceutical Introduction and Business Overview
10.2.3 Phio Pharmaceutical Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Phio Pharmaceutical Vector-Based RNAi Products Offered
10.2.5 Phio Pharmaceutical Recent Development
10.3 Quark Pharmaceuticals
10.3.1 Quark Pharmaceuticals Company Information
10.3.2 Quark Pharmaceuticals Introduction and Business Overview
10.3.3 Quark Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Quark Pharmaceuticals Vector-Based RNAi Products Offered
10.3.5 Quark Pharmaceuticals Recent Development
10.4 Thermo Fisher Scientific
10.4.1 Thermo Fisher Scientific Company Information
10.4.2 Thermo Fisher Scientific Introduction and Business Overview
10.4.3 Thermo Fisher Scientific Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Thermo Fisher Scientific Vector-Based RNAi Products Offered
10.4.5 Thermo Fisher Scientific Recent Development
10.5 Silence Therapeutics
10.5.1 Silence Therapeutics Company Information
10.5.2 Silence Therapeutics Introduction and Business Overview
10.5.3 Silence Therapeutics Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Silence Therapeutics Vector-Based RNAi Products Offered
10.5.5 Silence Therapeutics Recent Development
10.6 Qiagen NV
10.6.1 Qiagen NV Company Information
10.6.2 Qiagen NV Introduction and Business Overview
10.6.3 Qiagen NV Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Qiagen NV Vector-Based RNAi Products Offered
10.6.5 Qiagen NV Recent Development
10.7 Ionis Pharmaceutical
10.7.1 Ionis Pharmaceutical Company Information
10.7.2 Ionis Pharmaceutical Introduction and Business Overview
10.7.3 Ionis Pharmaceutical Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Ionis Pharmaceutical Vector-Based RNAi Products Offered
10.7.5 Ionis Pharmaceutical Recent Development
10.8 Dicerna Pharmaceuticals
10.8.1 Dicerna Pharmaceuticals Company Information
10.8.2 Dicerna Pharmaceuticals Introduction and Business Overview
10.8.3 Dicerna Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Dicerna Pharmaceuticals Vector-Based RNAi Products Offered
10.8.5 Dicerna Pharmaceuticals Recent Development
10.9 Arrowhead Pharmaceuticals
10.9.1 Arrowhead Pharmaceuticals Company Information
10.9.2 Arrowhead Pharmaceuticals Introduction and Business Overview
10.9.3 Arrowhead Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Arrowhead Pharmaceuticals Vector-Based RNAi Products Offered
10.9.5 Arrowhead Pharmaceuticals Recent Development
10.10 Arcturus Therapeutics
10.10.1 Arcturus Therapeutics Company Information
10.10.2 Arcturus Therapeutics Introduction and Business Overview
10.10.3 Arcturus Therapeutics Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Arcturus Therapeutics Vector-Based RNAi Products Offered
10.10.5 Arcturus Therapeutics Recent Development
10.11 Alnylam Pharmaceuticals
10.11.1 Alnylam Pharmaceuticals Company Information
10.11.2 Alnylam Pharmaceuticals Introduction and Business Overview
10.11.3 Alnylam Pharmaceuticals Vector-Based RNAi Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Alnylam Pharmaceuticals Vector-Based RNAi Products Offered
10.11.5 Alnylam Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vector-Based RNAi Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vector-Based RNAi Industrial Chain Analysis
11.4 Vector-Based RNAi Market Dynamics
11.4.1 Vector-Based RNAi Industry Trends
11.4.2 Vector-Based RNAi Market Drivers
11.4.3 Vector-Based RNAi Market Challenges
11.4.4 Vector-Based RNAi Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vector-Based RNAi Distributors
12.3 Vector-Based RNAi Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of siRNA Design
Table 2. Major Company of siRNA Vectors
Table 3. Major Company of Custom siRNA Construction
Table 4. Global Vector-Based RNAi Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Vector-Based RNAi Sales by Type (2024-2024) & (K Units)
Table 6. Global Vector-Based RNAi Sales Market Share in Volume by Type (2024-2024)
Table 7. Global Vector-Based RNAi Sales by Type (2024-2024) & (US& Million)
Table 8. Global Vector-Based RNAi Market Share in Value by Type (2024-2024)
Table 9. Global Vector-Based RNAi Price by Type (2024-2024) & (US$/Unit)
Table 10. Global Vector-Based RNAi Sales by Type (2024-2034) & (K Units)
Table 11. Global Vector-Based RNAi Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Vector-Based RNAi Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Vector-Based RNAi Sales Market Share in Value by Type (2024-2034)
Table 14. Global Vector-Based RNAi Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Vector-Based RNAi Sales by Type (2024-2024) & (K Units)
Table 16. North America Vector-Based RNAi Sales by Type (2024-2024) & (US$ Million)
Table 17. Europe Vector-Based RNAi Sales (K Units) by Type (2024-2024)
Table 18. Europe Vector-Based RNAi Sales by Type (2024-2024) & (US$ Million)
Table 19. Asia-Pacific Vector-Based RNAi Sales (K Units) by Type (2024-2024)
Table 20. Asia-Pacific Vector-Based RNAi Sales by Type (2024-2024) & (US$ Million)
Table 21. Latin America Vector-Based RNAi Sales (K Units) by Type (2024-2024)
Table 22. Latin America Vector-Based RNAi Sales by Type (2024-2024) & (US$ Million)
Table 23. Middle East and Africa Vector-Based RNAi Sales (K Units) by Type (2024-2024)
Table 24. Middle East and Africa Vector-Based RNAi Sales by Type (2024-2024) & (US$ Million)
Table 25. Global Vector-Based RNAi Sales by Company (2024-2024) & (K Units)
Table 26. Global Vector-Based RNAi Sales Share by Company (2024-2024)
Table 27. Global Vector-Based RNAi Revenue by Company (2024-2024) & (US$ Million)
Table 28. Global Vector-Based RNAi Revenue Share by Company (2024-2024)
Table 29. Global Market Vector-Based RNAi Price by Company (2024-2024) & (US$/Unit)
Table 30. Global Vector-Based RNAi Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Vector-Based RNAi Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vector-Based RNAi as of 2022)
Table 33. Date of Key Manufacturers Enter into Vector-Based RNAi Market
Table 34. Key Manufacturers Vector-Based RNAi Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Vector-Based RNAi Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 37. Global Vector-Based RNAi Sales by Region (2024-2024) & (K Units)
Table 38. Global Vector-Based RNAi Sales Market Share in Volume by Region (2024-2024)
Table 39. Global Vector-Based RNAi Sales by Region (2024-2024) & (US$ Million)
Table 40. Global Vector-Based RNAi Sales Market Share in Value by Region (2024-2024)
Table 41. Global Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 42. Global Vector-Based RNAi Sales by Region (2024-2034) & (K Units)
Table 43. Global Vector-Based RNAi Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Vector-Based RNAi Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Vector-Based RNAi Sales Market Share in Value by Region (2024-2034)
Table 46. Global Vector-Based RNAi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Vector-Based RNAi Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 48. Global Vector-Based RNAi Sales by Application (2024-2024) & (K Units)
Table 49. Global Vector-Based RNAi Sales Market Share in Volume by Application (2024-2024)
Table 50. Global Vector-Based RNAi Sales by Application (2024-2024) & (US$ Million)
Table 51. Global Vector-Based RNAi Sales Market Share in Value by Application (2024-2024)
Table 52. Global Vector-Based RNAi Price by Application (2024-2024) & (US$/Unit)
Table 53. Global Vector-Based RNAi Sales by Application (2024-2034) & (K Units)
Table 54. Global Vector-Based RNAi Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Vector-Based RNAi Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Vector-Based RNAi Sales Market Share in Value by Application (2024-2034)
Table 57. Global Vector-Based RNAi Price by Application (2024-2034) & (US$/Unit)
Table 58. North America Vector-Based RNAi Sales by Application (2024-2024) (K Units)
Table 59. North America Vector-Based RNAi Sales by Application (2024-2024) & (US$ Million)
Table 60. Europe Vector-Based RNAi Sales by Application (2024-2024) (K Units)
Table 61. Europe Vector-Based RNAi Sales by Application (2024-2024) & (US$ Million)
Table 62. Asia-Pacific Vector-Based RNAi Sales by Application (2024-2024) (K Units)
Table 63. Asia-Pacific Vector-Based RNAi Sales by Application (2024-2024) & (US$ Million)
Table 64. Latin America Vector-Based RNAi Sales by Application (2024-2024) (K Units)
Table 65. Latin America Vector-Based RNAi Sales by Application (2024-2024) & (US$ Million)
Table 66. Middle East and Africa Vector-Based RNAi Sales by Application (2024-2024) (K Units)
Table 67. Middle East and Africa Vector-Based RNAi Sales by Application (2024-2024) & (US$ Million)
Table 68. North America Vector-Based RNAi Sales by Country (2024-2024) & (K Units)
Table 69. North America Vector-Based RNAi Sales Market Share in Volume by Country (2024-2024)
Table 70. North America Vector-Based RNAi Sales by Country (2024-2024) & (US$ Million)
Table 71. North America Vector-Based RNAi Sales Market Share in Value by Country (2024-2024)
Table 72. North America Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 73. North America Vector-Based RNAi Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Vector-Based RNAi Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Vector-Based RNAi Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Vector-Based RNAi Sales by Country (2024-2024) & (K Units)
Table 77. Europe Vector-Based RNAi Sales Market Share in Volume by Country (2024-2024)
Table 78. Europe Vector-Based RNAi Sales by Country (2024-2024) & (US$ Million)
Table 79. Europe Vector-Based RNAi Sales Market Share in Value by Country (2024-2024)
Table 80. Europe Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 81. Europe Vector-Based RNAi Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Vector-Based RNAi Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Vector-Based RNAi Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Vector-Based RNAi Sales by Region (2024-2024) & (K Units)
Table 85. Asia-Pacific Vector-Based RNAi Sales Market Share in Volume by Region (2024-2024)
Table 86. Asia-Pacific Vector-Based RNAi Sales by Region (2024-2024) & (US$ Million)
Table 87. Asia-Pacific Vector-Based RNAi Sales Market Share in Value by Region (2024-2024)
Table 88. Asia-Pacific Vector-Based RNAi Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Vector-Based RNAi Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Vector-Based RNAi Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Vector-Based RNAi Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Vector-Based RNAi Sales by Country (2024-2024) & (K Units)
Table 93. Latin America Vector-Based RNAi Sales Market Share in Volume by Country (2024-2024)
Table 94. Latin America Vector-Based RNAi Sales by Country (2024-2024) & (US$ Million)
Table 95. Latin America Vector-Based RNAi Sales Market Share in Value by Country (2024-2024)
Table 96. Latin America Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Vector-Based RNAi Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Vector-Based RNAi Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Vector-Based RNAi Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Vector-Based RNAi Sales by Country (2024-2024) & (K Units)
Table 101. Middle East and Africa Vector-Based RNAi Sales Market Share in Volume by Country (2024-2024)
Table 102. Middle East and Africa Vector-Based RNAi Sales by Country (2024-2024) & (US$ Million)
Table 103. Middle East and Africa Vector-Based RNAi Sales Market Share in Value by Country (2024-2024)
Table 104. Middle East and Africa Vector-Based RNAi Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Vector-Based RNAi Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Vector-Based RNAi Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Vector-Based RNAi Sales Market Share in Value by Country (2024-2034)
Table 108. Merck & Co. Company Information
Table 109. Merck & Co. Introduction and Business Overview
Table 110. Merck & Co. Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 111. Merck & Co. Vector-Based RNAi Product
Table 112. Merck & Co. Recent Development
Table 113. Phio Pharmaceutical Company Information
Table 114. Phio Pharmaceutical Introduction and Business Overview
Table 115. Phio Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 116. Phio Pharmaceutical Vector-Based RNAi Product
Table 117. Phio Pharmaceutical Recent Development
Table 118. Quark Pharmaceuticals Company Information
Table 119. Quark Pharmaceuticals Introduction and Business Overview
Table 120. Quark Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 121. Quark Pharmaceuticals Vector-Based RNAi Product
Table 122. Quark Pharmaceuticals Recent Development
Table 123. Thermo Fisher Scientific Company Information
Table 124. Thermo Fisher Scientific Introduction and Business Overview
Table 125. Thermo Fisher Scientific Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 126. Thermo Fisher Scientific Vector-Based RNAi Product
Table 127. Thermo Fisher Scientific Recent Development
Table 128. Silence Therapeutics Company Information
Table 129. Silence Therapeutics Introduction and Business Overview
Table 130. Silence Therapeutics Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 131. Silence Therapeutics Vector-Based RNAi Product
Table 132. Silence Therapeutics Recent Development
Table 133. Qiagen NV Company Information
Table 134. Qiagen NV Introduction and Business Overview
Table 135. Qiagen NV Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 136. Qiagen NV Vector-Based RNAi Product
Table 137. Qiagen NV Recent Development
Table 138. Ionis Pharmaceutical Company Information
Table 139. Ionis Pharmaceutical Introduction and Business Overview
Table 140. Ionis Pharmaceutical Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 141. Ionis Pharmaceutical Vector-Based RNAi Product
Table 142. Ionis Pharmaceutical Recent Development
Table 143. Dicerna Pharmaceuticals Company Information
Table 144. Dicerna Pharmaceuticals Introduction and Business Overview
Table 145. Dicerna Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 146. Dicerna Pharmaceuticals Vector-Based RNAi Product
Table 147. Dicerna Pharmaceuticals Recent Development
Table 148. Arrowhead Pharmaceuticals Company Information
Table 149. Arrowhead Pharmaceuticals Introduction and Business Overview
Table 150. Arrowhead Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 151. Arrowhead Pharmaceuticals Vector-Based RNAi Product
Table 152. Arrowhead Pharmaceuticals Recent Development
Table 153. Arcturus Therapeutics Company Information
Table 154. Arcturus Therapeutics Introduction and Business Overview
Table 155. Arcturus Therapeutics Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 156. Arcturus Therapeutics Vector-Based RNAi Product
Table 157. Arcturus Therapeutics Recent Development
Table 158. Alnylam Pharmaceuticals Company Information
Table 159. Alnylam Pharmaceuticals Introduction and Business Overview
Table 160. Alnylam Pharmaceuticals Vector-Based RNAi Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 161. Alnylam Pharmaceuticals Vector-Based RNAi Product
Table 162. Alnylam Pharmaceuticals Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Vector-Based RNAi Market Trends
Table 166. Vector-Based RNAi Market Drivers
Table 167. Vector-Based RNAi Market Challenges
Table 168. Vector-Based RNAi Market Restraints
Table 169. Vector-Based RNAi Distributors List
Table 170. Vector-Based RNAi Downstream Customers
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Vector-Based RNAi Product Picture
Figure 2. Global Vector-Based RNAi Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Vector-Based RNAi Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Vector-Based RNAi Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of siRNA Design
Figure 6. Global siRNA Design Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of siRNA Vectors
Figure 8. Global siRNA Vectors Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Custom siRNA Construction
Figure 10. Global Custom siRNA Construction Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Global Vector-Based RNAi Sales by Type (2024-2034) & (US$ Million)
Figure 12. Global Vector-Based RNAi Sales Market Share by Type in 2022 & 2034
Figure 13. North America Vector-Based RNAi Sales Market Share in Volume by Type in 2022
Figure 14. North America Vector-Based RNAi Sales Market Share in Value by Type in 2022
Figure 15. Europe Vector-Based RNAi Sales Market Share in Volume by Type in 2022
Figure 16. Europe Vector-Based RNAi Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Vector-Based RNAi Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Vector-Based RNAi Sales Market Share in Value by Type in 2022
Figure 19. Latin America Vector-Based RNAi Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Vector-Based RNAi Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Vector-Based RNAi Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Vector-Based RNAi Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Vector-Based RNAi Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Vector-Based RNAi Revenue in 2022
Figure 25. Vector-Based RNAi Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 26. Product Picture of Hospitals
Figure 27. Global Hospitals Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Speciality Clinics
Figure 29. Global Speciality Clinics Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Vector-Based RNAi Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Vector-Based RNAi Sales Market Share by Application in 2022 & 2034
Figure 32. North America Vector-Based RNAi Sales Market Share in Volume by Application in 2022
Figure 33. North America Vector-Based RNAi Sales Market Share in Value by Application in 2022
Figure 34. Europe Vector-Based RNAi Sales Market Share in Volume by Application in 2022
Figure 35. Europe Vector-Based RNAi Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Vector-Based RNAi Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Vector-Based RNAi Sales Market Share in Value by Application in 2022
Figure 38. Latin America Vector-Based RNAi Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Vector-Based RNAi Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Vector-Based RNAi Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Vector-Based RNAi Manufacturing Cost Structure
Figure 43. Vector-Based RNAi Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries